Ghent University Academic Bibliography

Advanced

Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B

Xavier Verhelst UGent, Hans Orlent, Isabelle Colle UGent, Anja Geerts UGent, MARTINE DE VOS UGent and Hans Van Vlierberghe UGent (2010) EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 22(4). p.494-499
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
hepatitis B virus infection, anti-TNF alpha therapy, immunosuppression, liver failure, reactivation, rheumatoid arthritis, MODIFYING ANTIRHEUMATIC DRUGS, FACTOR-ALPHA THERAPY, INFLIXIMAB THERAPY, CROHNS-DISEASE, VIRUS, REACTIVATION, LIVER, PROPHYLAXIS, INFECTIONS, SPONDYLOARTHROPATHY
journal title
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Eur. J. Gastroenterol. Hepatol.
volume
22
issue
4
pages
494 - 499
Web of Science type
article
Web of Science id
000276566100017
JCR category
GASTROENTEROLOGY & HEPATOLOGY
JCR impact factor
1.598 (2010)
JCR rank
48/71 (2010)
JCR quartile
3 (2010)
ISSN
0954-691X
DOI
10.1097/MEG.0b013e3283329d13
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1002264
handle
http://hdl.handle.net/1854/LU-1002264
date created
2010-07-05 12:13:42
date last changed
2010-07-08 11:36:02
@article{1002264,
  author       = {Verhelst, Xavier and Orlent, Hans and Colle, Isabelle and Geerts, Anja and DE VOS, MARTINE and Van Vlierberghe, Hans},
  issn         = {0954-691X},
  journal      = {EUROPEAN JOURNAL OF GASTROENTEROLOGY \& HEPATOLOGY},
  keyword      = {hepatitis B virus infection,anti-TNF alpha therapy,immunosuppression,liver failure,reactivation,rheumatoid arthritis,MODIFYING ANTIRHEUMATIC DRUGS,FACTOR-ALPHA THERAPY,INFLIXIMAB THERAPY,CROHNS-DISEASE,VIRUS,REACTIVATION,LIVER,PROPHYLAXIS,INFECTIONS,SPONDYLOARTHROPATHY},
  language     = {eng},
  number       = {4},
  pages        = {494--499},
  title        = {Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B},
  url          = {http://dx.doi.org/10.1097/MEG.0b013e3283329d13},
  volume       = {22},
  year         = {2010},
}

Chicago
Verhelst, Xavier, Hans Orlent, Isabelle Colle, Anja Geerts, MARTINE DE VOS, and Hans Van Vlierberghe. 2010. “Subfulminant Hepatitis B During Treatment with Adalimumab in a Patient with Rheumatoid Arthritis and Chronic Hepatitis B.” European Journal of Gastroenterology & Hepatology 22 (4): 494–499.
APA
Verhelst, X., Orlent, H., Colle, I., Geerts, A., DE VOS, M., & Van Vlierberghe, H. (2010). Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 22(4), 494–499.
Vancouver
1.
Verhelst X, Orlent H, Colle I, Geerts A, DE VOS M, Van Vlierberghe H. Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2010;22(4):494–9.
MLA
Verhelst, Xavier, Hans Orlent, Isabelle Colle, et al. “Subfulminant Hepatitis B During Treatment with Adalimumab in a Patient with Rheumatoid Arthritis and Chronic Hepatitis B.” EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 22.4 (2010): 494–499. Print.